Drug Recalls
Whether you are a pharmacist, wholesaler, or manufacturer, you realize that the medication recall process requires drastic improvement. I have experienced this first hand as a pharmacist. There were several times when patients would come to the pharmacy and tell me they heard their medication was recalled; I hadn’t even received a fax notification about …
Advancing Patient Adherence: Leveraging Serialization & ADLT™ from Manufacturer to Patient
According to a 2014 Whitepaper by The ThomsenGroup, “.. non-adherence with prescription regimens is now a $300 billion problem in the US. The NCBI (National Center for Biotechnology Information )..noted that almost 50% of all prescribed medications are not taken according to directions…and nearly 25% are never initiated.” Non-adherence is problematic both from a National …
Improved Inventory Management
In the biopharma industry, inventory management is complicated by the fact that manufacturers do not have visibility into the post or pre-manufacturing supply chain and, as we provide lifesaving medications, there is a necessity to ensure that there is a sufficient supply to serve our patients. In some cases, there may also be a regulatory …
ADLT™ and Getting a handle on API Inventory
Recently, I spoke to a Pharma Company and asked them how much visibility they had into the manufacturing of APIs and other raw ingredients. The representative responded: “We don’t have any visibility into the API’s”. As with the rest of the supply chain, this lack of visibility has a significant impact on inventory levels and …